Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $39.8500 (-2.33%) ($39.4500 - $41.9000) on Fri. Sep. 21, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.99% (three month average) | RSI | 46 | Latest Price | $39.8500(-2.33%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.6% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.1% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(59%) ARKG(52%) IBB(51%) IWO(50%) ARKK(49%) | Factors Impacting ATRA price | ATRA will decline at least -1.495% in a week (0% probabilities). VXX(-14%) VIXM(-14%) TLT(-14%) UUP(-12%) UNG(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.495% (StdDev 2.99%) | Hourly BBV | 0 () | Intraday Trend | -2.2% | | | |
|
Resistance Level | $39.99 | 5 Day Moving Average | $39.89(-0.1%) | 10 Day Moving Average | $40.23(-0.94%) | 20 Day Moving Average | $39.99(-0.35%) | To recent high | -13.5% | To recent low | 13.7% | Market Cap | $2.961b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |